Supernus Pharmaceuticals Inc

XNAS: SUPN

Strong Performer, Under Radar

Download real time

32.70 0.55 (1.71%)

28.08% Gain from 52W Low

380.5K XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

1,825.1

Market Cap

Below industry Median

-0.1

Beta 1Year

Very Low volatility

Supernus Pharmaceuticals Inc - SUPN - stock price prediction, stock price target, analyst ratings from 5 analysts

Supernus Pharmaceuticals Inc has a share price target of US$ 39, revenue growth forecast of -5.8%, and profit growth estimate of -85.0% for FY25, based on top 5 analyst calls.

Forecaster Screeners